Garcia-Beltran, C, Cereijo, R, Plou, C, Gavalda-Navarro, A, Malpique, R, Villarroya, J, Lopez-Bermejo, A, de Zegher, F, Ibanez, L, Villarroya, F. Posterior Cervical Brown Fat and CXCL14 Levels in the First Year of Life: Sex Differences and Association With Adiposity. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2022; 107(3)DOI:10.1210/clinem/dgab761. PMID:34677618. IF:5.800(Q1/3D).

Domingo, P, Mateo, MG, Villarroya, J, Cereijo, R, Torres, F, Domingo, JC, Campderros, L, Gallego-Escuredo, JM, Gutierrez, MD, Mur, I, Corbacho, N, Vidal, F, Villarroya, F, Giralt, M. Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy. Journal of Clinical Medicine. 2022; 11(3)DOI:10.3390/jcm11030549. PMID:35160008. IF:3.900(Q2/4D).

Yeregui, E, Masip, J, Vilades, C, Domingo, P, Pacheco, YM, Blanco, J, Mallolas, J, Alba, V, Vargas, M, Garcia-Pardo, G, Negredo, E, Olona, M, Vidal-Gonzalez, J, Peraire, M, Marti, A, Reverte, L, Gomez-Bertomeu, F, Leal, M, Vidal, F, Peraire, J, Rull, A. Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4(+) T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(4)DOI:10.3390/ijms23042202. PMID:35216318. IF:5.600(Q1/3D).

Collazos, J, Domingo, P, Fernandez-Araujo, N, Asensi-Diaz, E, Vilchez-Rueda, H, Lalueza, A, Roy-Vallejo, E, Blanes, R, Raya-Cruz, M, Sanz-Canovas, J, Artero, A, Ramos-Rincon, JM, Duenas-Gutierrez, C, Lamas-Ferreiro, JL, Asensi, V. Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19. PLoS One. 2022; 17(1)DOI:10.1371/journal.pone.0262777. PMID:35085321. IF:3.700(Q2/4D).

Domingo, P, de Benito, N. Alpha variant SARS-CoV-2 infection: How it all starts. EBioMedicine. 2021; 74DOI:10.1016/j.ebiom.2021.103703. PMID:34800902. IF:11.205(Q1/2D).

Camps-Vilaró, A, Teira, R, Subirana, I, Dégano, IR, Domingo, P, Curran, A, Montero-Alonso, M, Romero, A, Marrugat, J, Galindo, MJ. Age-standardized comparison of coronary artery disease, stroke incidence, and all-cause mortality between people living with HIV and the general population in Spain. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2025; 160DOI:10.1016/j.ijid.2025.108061. PMID:40953693. IF:4.300(Q1/2D).

de Lazzari, E, Di Gregorio, S, Rojas, J, Curran, A, Domingo, P, Negredo, E, Tiraboschi, J, Gonzalez-Cordon, A, Torres, B, Sempere, A, Inciarte, A, Gatell, JM, Blanco, JL, Martinez, E. 48 Week body composition changes in persons with HIV switching to dolutegravir plus lamivudine: a planned subanalysis of the DOLAM randomized clinical trial. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2025; 80(8)DOI:10.1093/jac/dkaf192. PMID:40556520. IF:3.600(Q2/3D).

Giralt, M, Domingo, P, Quesada-López, T, Cereijo, R, Villarroya, F. Lipodystrophy in HIV: Evolving Challenges and Unresolved Questions. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(14)DOI:10.3390/ijms26146546. PMID:40724797. IF:4.900(Q1/3D).

Ryan, P, Blanco, JL, Masia, M, Garcia-Fraile, L, Crusells, MJ, Domingo, P, Curran, A, Guerri-Fernandez, R, Bernal, E, Bravo, J, Revollo, B, Macias, J, Tiraboschi, JM, Montejano, R, Amador, C, Torralba, M, Merino, D, Diaz-Brito, V, Galindo, MJ, Ferra, S, Villoslada, A, Losa, JE, Fanjul, FJ, Perez-Stachowski, X, Peraire, J, Portilla, J, de la Fuente, S, Dueñas, C, Vazquez, MJ, Di Gregorio, S, Esteban, H, Gil, P, de Miguel, M, Alejos, B, Martínez, E. Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial. Lancet HIV. 2025; 12(7)DOI:10.1016/S2352-3018(25)00105-5. PMID:40489982. IF:13.000(Q1/1D).

Rogg, L, Nuñez, SA, Mingrone, MVO, Domingo, P, Lopez, M, Hanan, N, Ghita, GL, Jeffrey, JL, Underwood, M, Castillo-Mancilla, JR, Halliday, F, Ezeadi, E, Gartland, M. Antiviral effect, safety, and tolerability of the third-generation integrase strand transfer inhibitor VH4524184 (VH-184): a proof-of-concept trial. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

Bailón, L, Moltó, J, Curran, A, Cadiñanos, J, de Quirós, JCLB, de los Santos, I, Ambrosioni, J, Imaz, A, Benet, S, Suanzes, P, Navarro, J, González-García, J, Busca, C, Pérez-Latorre, L, Berenguer, J, García-Fraile, LJ, Mejia-Abril, G, Miró, JM, Scévola, S, Moreno, S, Domingo, P, Tian, Y, Frankot, M, Lim, D, Cai, YH, Vendrame, E, Guo, S, Wallin, JJ, Geleziunas, R, Sengupta, D, Alarcón-Soto, Y, Leal, I, Aranguen, A, Garcia-Garcia, M, McGowan, I, Brander, C, Arribas, JR, Mothe, B. Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial. Nature Communications. 2025; 16(1)DOI:10.1038/s41467-025-57284-w. PMID:40038256. IF:15.700(Q1/1D).

Suades, R, Greco, MF, Padró, T, de Santisteban, V, Domingo, P, Benincasa, G, Napoli, C, Greco, S, Madè, A, Ranucci, M, Devaux, Y, Martelli, F, Badimon, L. Blood CD45+/CD3+ lymphocyte-released extracellular vesicles and mortality in hospitalized patients with coronavirus disease 2019. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2025; 55(2)DOI:10.1111/eci.14354. PMID:39548690. IF:3.600(Q1/2D).

Bruguera, A, Nomah, DK, Moreno-Fornés, S, Martinez, E, Negredo, E, Tiraboschi, J, Navarro, J, Domingo, P, Fanjul, F, Villoslada, A, Peraire, J, Jaen, A, Miró JM, Casabona, J, Reyes-Urueña, J. Epidemiological, clinical and mortality trends in people with HIV over 60 years in the PISCIS population-based cohort from Catalonia and Balearic Islands. AIDS. 2025; 39(1)DOI:10.1097/QAD.0000000000004018. PMID:39639721. IF:3.100(Q2/4D).

Pan Y.-H., Nomah D.K., Montoro-Fernandez M., Moreno-Fornés S., Díaz Y., Aceitón J., Bruguera A., Llibre J.M., Domingo P., Imaz A., Vilaró I., Falcó V., Reyes-Urueña J., Miro J.M., Casabona J.. The impact of the COVID-19 pandemic on healthcare services utilization among people living with HIV in Catalonia, Spain: A population-based cohort study. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2024; 42(10)DOI:10.1016/j.eimc.2023.09.001. PMID:38218704. IF:2.500(Q2/5D).

Karaduzovic-Hadziabdic, K, Adilovic, M, Zhang, L, Lumley, A, Shah, PA, Shoaib, M, Satagopam, V, Srivastava, PK, Emanueli, C, Greco, S, Made, A, Padro, T, Domingo, P, Lustrek, M, Scholz, M, Rosolowski, M, Jordan, M, Benczik, B, Agg, B, Ferdinandy, P, Baker, AH, Fagherazzi, G, Ollert, M, Michel, J, Sanchez, G, Firat, H, Brandenburger, T, Martelli, F, Badimon, L, Devaux, Y. Prediction of COVID-19 severity using machine learning. Clinical and Translational Medicine. 2024; 14(10)DOI:10.1002/ctm2.70042. PMID:39370709. IF:6.800(Q1/2D).

Díaz, M, Quesada, T, Villarroya, F, López-Bermejo, A, Casano, P, De Zegher, F, Ibanez, L. The proteome of circulating exosomes in appropriate- versus small-for-gestational-age infants: differentially expressed proteins at birth associate with measures of weight gain, liver fat, insulin resistance and adrenarche at age 7. Hormone Research in Paediatrics. 2024; 97DOI:. PMID:. IF:2.700(Q1/2D).

Suades, R, Greco, MF, Prieto, P, Padro, T, Devaux, Y, Domingo, P, Badimon, L. CD66b⁺/CD68⁺ circulating extracellular vesicles, lactate dehydrogenase and neutrophil-to-lymphocyte ratio can differentiate coronavirus disease 2019 severity during and after infection. Journal of Extracellular Vesicles. 2024; 13(7)DOI:10.1002/jev2.12456. PMID:39007437. IF:14.500(Q1/1D).

Ryan, P, Blanco, JL, Masia, M, Garcia-Fraile, L, Crusells, MJ, Domingo, P, Curran, A, Guerri-Fernandez, R, Bernal, E, Bravo, J, Revollo, B, Macias, J, Tiraboschi, JM, Montejano, R, Amador, C, Torralba, M, Merino, D, Diaz-Brito, V, Galindo, MJ, Ferra, S, Villoslada, A, Losa, JE, Fanjul, FJ, Perez-Stachowski, J, Peraire, J, Portilla, J, de la Fuente, S, Dueñas, C, Vazquez, MJ, Di Gregorio, S, Manzanares, E, Gil, P, de Miguel, M, Alejos, B, Martinez, E. Non-inferior efficacy and less weight gain when switching to DTG/3TC than when switching to BIC/FTC/TAF in virologically suppressed people with HIV (PWH): the PASO-DOBLE (GeSIDA 11720) randomized clinical trial. Journal of the International AIDS Society. 2024; 27DOI:. PMID:. IF:4.900(Q1/2D).

Suades, R, Padró, T, Domingo, P, Greco, MF, Benincasa, G, Greco, S, Madè, A, Ranucci, M, Devaux, Y, Martelli, F, Badimon, L. Blood immune and endothelial cell-released extracellular vesicle changes relate to COVID-19 mortality in hospitalized patients. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).

Berenguer, J, Jarrín, I, Bellón, JM, Díez, C, Jiménez-Sousa, MA, López, JC, Pinto-Martínez, A, Moreno, S, Montes, ML, Iribarren, JA, Orviz, E, Portilla, J, Villarroya, F, Domingo, P, Resino, S. Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients With HIV. JOURNAL OF INFECTIOUS DISEASES. 2024; 230(2)DOI:10.1093/infdis/jiae168. PMID:38557859. IF:4.500(Q1/2D).